Atenolol in the treatment of essential hypertension during pregnancy.
Open Access
- 1 August 1982
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 14 (2) , 279-281
- https://doi.org/10.1111/j.1365-2125.1982.tb01974.x
Abstract
Atenolol has been studied prospectively in the management of ten patients with essential hypertension during pregnancy. Median supine BP fell significantly from 156/98 mmHg before treatment to 128/82 mmHg at term. Atenolol did not suppress cardiotocographic signs of foetal distress. Although there was one intrauterine death, the remaining nine babies had a median Apgar score at birth of 9 and a median weight which was 82% of the gestational mean. There were no cases of neonatal bradycardia or respiratory depression and the only case of hypoglycaemia was in a dysmature baby. These findings justify a formal study of beta‐adrenoceptor blocker therapy in hypertensive diseases of pregnancy.This publication has 4 references indexed in Scilit:
- Beta-Blockers in PregnancyNew England Journal of Medicine, 1981
- Atenolol in the treatment of pregnancy-induced hypertension.Published by Wiley ,1981
- The electronic evaluation of the fetal heart rate. V. The vagal factor in fetal bradycardia.1961
- The electronic evaluation of the fetal heart rateAmerican Journal of Obstetrics and Gynecology, 1961